SHARED SERVICES AGREEMENTShared Services Agreement • September 7th, 2022 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus • Delaware
This Shared Services Agreement, dated and effective as of August 31, 2022 (this “Agreement”), is entered into between Interpace Pharma Solutions, Inc., a Delaware corporation (“Company”) and Interpace Biosciences, Inc., a Delaware corporation (“Shareholder” and collectively with Company, “Seller”), and Flagship Biosciences, Inc. a Delaware limited liability company (“Buyer”).
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • September 7th, 2022 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus • Delaware
Asset Purchase Agreement (this “Agreement”), dated this 31st day of August 2022 (the “Execution Date”), by and among Flagship Biosciences, Inc., a Delaware corporation (the “Purchaser”), Interpace Pharma Solutions, Inc., a Delaware corporation (the “Company”), and Interpace Biosciences, Inc., a Delaware corporation (the “Shareholder”).
